The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Fight Against the Medicare Part B Demonstration Project

The Fight Against the Medicare Part B Demonstration Project

October 28, 2016 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Legal_500x270Biologics have been hailed by the American College of Rheumatology (ACR) as a “remarkable public health victory.” But if patients don’t have access to a treatment that has cut the rheumatoid arthritis (RA) progression rate in half since 1990, then what good is it?

You Might Also Like
  • The ACR Continues Fight to Block Medicare Part B Demo Project: Rule Expected in Fall 2016
  • CMS Cancels Medicare Part B Demonstration Project
  • ACR Leads Fight Against Proposed Reimbursement Cuts to E/M Services
Also By This Author
  • Expert Q&A: Dr. Michael Lockshin on APS

That’s one reason why Angus Worthing, MD, FACP, FACR, and the incoming chair of ACR’s Government Affairs Committee, says the ACR is fighting a proposed demonstration project from the Centers for Medicare & Medicaid Services (CMS) that would change how Medicare Part B pays rheumatologists and others for medication. Typically, the payment is the average sales price of a drug plus a 6% add-on. The demonstration project would “test whether changing the add-on payment to 2.5% plus a flat-fee payment of $16.80 per drug per day changes prescribing incentives and leads to improved quality and value.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR and 315 other organizations have publicly said savings would not be achieved. And although the comment period for the new rule closed earlier this year, no decision has yet been rendered. The rule would not go into effect any sooner than 60 days after it is finalized, so a decision needs to be made in the next few weeks for the proposal to go live this year.

“We’re hoping that Medicare would decide to change this in either one of a couple of ways or not go forward with it,” says Dr. Worthing, a practicing rheumatologist in Chevy Chase, Md. “If it goes forward the way it’s proposed, we’re pretty worried about how it might reduce access to biologics given in the office.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In lobbying CMS and members of the U.S. Congress, Dr. Worthing and the ACR suggested that the proposed rule was unnecessary.

“Given the success of the current Part B reimbursement methodology in ensuring patient access to the most appropriate treatments, it is unclear what ‘deficits in care’ CMS is attempting to address in this incredibly wide-ranging initiative,” the ACR wrote in a letter earlier this year.

Dr. Worthing says the CMS should withdraw the proposal. However, if it does move forward, the ACR has urged modifications that would blunt its impact to rank-and-file rheumatologists.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Limiting the scope of it or changing the amount of the cut in reimbursement of medications … might help,” he says.

Among the proposed changes the ACR is endorsing would be exemptions to protect what it calls “the most vulnerable Medicare beneficiaries.” It would push to exempt physician groups of 25 or fewer professionals and exculpate physician-owned practices in rural or medically underserved areas. Dr. Worthing says the figure of 25 professionals is an educated guess on where to draw the proverbial line in the sand.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Advocacy, Centers for Medicare and Medicaid Services (CMS), Congress, Medicare, Medicare Part B, Medicare Reimbursement, Reimbursement

You Might Also Like:
  • The ACR Continues Fight to Block Medicare Part B Demo Project: Rule Expected in Fall 2016
  • CMS Cancels Medicare Part B Demonstration Project
  • ACR Leads Fight Against Proposed Reimbursement Cuts to E/M Services
  • What You Need to Know about the New Medicare Card Project

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.